Clinical and Angiographic Outcomes in Diabetics From the ENDEAVOR IV Trial. Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease

JACC: Cardiovascular Interventions

Volumn 2, Issue 10, 2009, Pages 967-976

  Kirtane, Ajay J ^a   Patel, Rikesh ^a   O'Shaughnessy, Charles ^b   Overlie, Paul ^c   McLaurin, Brent ^d   Solomon, Stuart ^e   Mauri, Laura ^f   Fitzgerald, Peter ^g   Popma, Jeffrey J ^h   Kandzari, David E ⁱ   Leon, Martin B ^a  

^a NewYork Presbyterian Hospital   (United States)

^b Elyria Memorial Hospital   (United States)

^c Lubbock Heart Hospital   (United States)

^d Anderson Medical Center   (United States)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^g STANFORD UNIVERSITY   (United States)

^h ST ELIZABETH'S MEDICAL CENTER   (United States)

ⁱ SCRIPPS CLINIC   (United States)

Author keywords

diabetes mellitus; drug eluting stent; Endeavor IV; zotarolimus

Indexed keywords

PACLITAXEL; ZOTAROLIMUS;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAFETY; SINGLE BLIND PROCEDURE; STENT THROMBOSIS; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DIABETIC ANGIOPATHIES; DRUG-ELUTING STENTS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 70350034013     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.08.008     Document Type: Article

References (20)

1. Cutlip D.E., Chhabra A.G., Baim D.S., et al. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation 110 (2004) 1226-1230
2. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
3. Lee T.T., Feinberg L., Baim D.S., et al. Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials). Am J Cardiol 98 (2006) 718-721
4. Kastrati A., Mehilli J., Pache J., et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 1030-1039
5. Spaulding C., Daemen J., Boersma E., Cutlip D.E., and Serruys P.W. A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents. N Engl J Med 356 (2007) 989-997
6. Kirtane A.J., Ellis S.G., Dawkins K.D., et al. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. J Am Coll Cardiol 51 (2008) 708-715
7. Garg P., Normand S.L., Silbaugh T.S., et al. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry. Circulation 118 (2008) 2277-2285 7p following 2285
8. Sabate M., Jimenez-Quevedo P., Angiolillo D.J., et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 112 (2005) 2175-2183
9. Baumgart D., Klauss V., Baer F., et al. One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients. J Am Coll Cardiol 50 (2007) 1627-1634
10. Stettler C., Allemann S., Wandel S., et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ 337 (2008) a1331
11. Ortolani P., Balducelli M., Marzaroli P., et al. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry. Circulation 117 (2008) 923-930
12. Fajadet J., Wijns W., Laarman G.-J., et al. Randomized, double-blind, multicenter study of the endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation 114 (2006) 798-806
13. Leon MB. ENDEAVOR 4: A Randomized Comparison of a Zotarolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease: 8-Month Angiographic and 9- and 12-Month Clinical Results. Presented at: Transcatheter Cardiovascular Therapeutics; October 22, 2007; Washington, DC.
14. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
15. Kandzari D.E., Leon M.B., Popma J.J., et al. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol 48 (2006) 2440-2447
16. Kirtane A.J., Ellis S.G., Dawkins K.D., et al. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. J Am Coll Cardiol 51 (2008) 708-715
17. Pinto D.S., Stone G.W., Ellis S.G., et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol 48 (2006) 32-36
18. Jeremias A., and Kirtane A. Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention. Ann Intern Med 148 (2008) 234-238
19. Garg P., Cohen D.J., Gaziano T., and Mauri L. Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model. J Am Coll Cardiol 51 (2008) 1844-1853
20. Daemen J., Garcia-Garcia H.M., Kukreja N., et al. The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus. Eur Heart J 28 (2007) 26-32